ecigare)es: promise!or!peril? · pdf file · 2015-05-05& children’s...

45
Ecigare)es: Promise or Peril? Susanne Tanski, MD, MPH, FAAP Department of Pediatrics, Geisel School of Medicine at Dartmouth & Children’s Hospital at Dartmouth Dartmouth Media Research Lab, Norris Cotton Cancer Center AAP Julius B. Richmond Center of Excellence 10 th Annual NH Comprehensive Cancer Collaboration Annual Conference April 1, 2015

Upload: ngokhanh

Post on 09-Mar-2018

213 views

Category:

Documents


0 download

TRANSCRIPT

E-­‐cigare)es:  

Promise  or  Peril? Susanne Tanski, MD, MPH, FAAP

Department of Pediatrics, Geisel School of Medicine at Dartmouth & Children’s Hospital at Dartmouth

Dartmouth Media Research Lab, Norris Cotton Cancer Center AAP Julius B. Richmond Center of Excellence

     

10th Annual NH Comprehensive Cancer Collaboration Annual Conference

April 1, 2015

Objec/ves  –  e-­‐cigare5es  and  “vaping”  devices  

•  Who  is  using  them  

•  What  are  they  

•  Public  and  individual  health  concerns  –  Safety  of  devices/poisoning  risk    –  Poten;al  for  adolescent  nico;ne  addic;on  –  Poten;al  to  glamourize  and  re-­‐normalize  smoking    –  Evidence  for  cessa;on/dual  use    –  Evidence  for  effects  of  second-­‐hand  vapor    exposure    

E-­‐cigare)e  Prevalence  2013  •  6.1%  of  youth  (6-­‐12  grades)  had  ever  tried  e-­‐cigareHe  

–  From  NYTS  2013    -­‐  >  3x  rate  from  2011  –  20.2%  of  ever-­‐cigareHe  smokers  and  0.9%  of  never  smokers  

•  Current  US  e-­‐cigareHe  use      -­‐  6.9%  ever-­‐smokers      -­‐  0.3%  never-­‐smokers  

•  Utah  -­‐    5.9%  current  

•  Hawaii  -­‐    29%  ever        18%  current  

Bunnell et al. Nicotine and Tobacco Research, 2014; Wills, in press

Legacy  US  2014  data  Ever  and  Current  Use  of  E-­‐Cigs  

Monitoring  the  Future,  2014  Current  Use  (30  day)  Cigare)e  vs.  E-­‐Cig  

4  

7  

14  

9  

16  17  

0  

2  

4  

6  

8  

10  

12  

14  

16  

18  

8th  Grade   10th  Grade   12th  Grade  

CigareHes  

E-­‐cigs  

Trends  in  adult  current  use    of  e-­‐cigare)es    2010-­‐2013  

McMillen, et al. “Trends in electronic cigarette use among US adults. In press, 2014

0  

2  

4  

6  

8  

10  

12  

14  

16  

Overall   18-­‐24  years   25-­‐44  years   45-­‐64  years   65+  years  

2010  

2011  

2012  

2013  

What  are  e-­‐cigare)es?  

Rachel Grana et al. Circulation. 2014;129:1972-1986

From  Cigare)e  to  Vapor  Pen,  an  evoluMon  in  technology:  Cig-­‐alikes,  

Tanks  and  Mods  

•  GRAS  classifica;on:      –  Generally  recognized  as  safe  for  use  IN  FOOD  –  Based  on  scien;fic  evidence,  or,  for  a  substance  used  in  food  before  1958,  through  experience  based  on  common  use  in  food  by  “substan;al  history  of  consump;on  for  food  use  by  a  significant  number  of  consumers.”  

•  Exclusions  made  for  certain  things    –  Propylene  glycol  is  excluded  from  cat  food  due  to  Heinz  body  anemia  

ConsMtuents  of  e-­‐juice:  humectant,  flavoring,  +/-­‐  nicoMne    

ConsMtuents  of  e-­‐juice:  humectants:  PG/VG  

•  Propylene  glycol:  general  recognized  as  safe  –  Few  human  studies  for  inhala;on,  however  has  been  used  as  a  tobacco  humectant  historically  

•  Can  cause  eye  and  respiratory  irrita;on  •  MSDS  from  Dow  Chemical  states  “inhala;on  exposure  to  [propylene  glycol]  mists  should  be  avoided”  

•  Vegetable  glycerin:  generally  recognized  as  safe  – When  heated  and  vaporized,  can  form  acrolein,  which  can  cause  upper  respiratory  irrita;on    

•  For  all:  unknown  long-­‐term  health  impacts  from  repeated  inhala;on  

Werley et al, Toxicology 2011

Humectant  Toxicity  –  recent  evidence  

Kosmider et al, Nicotine & Tobacco Research 2014

ConsMtuents  of  e-­‐juice:  Flavorings  

•  Have  NOT  been  assessed  for  safety  as  inhalants  •  American  e-­‐Liquid  Manufacturing  Standards  Associa;on  does  not  allow:  –  Diacetyl,  whole  tobacco  alkaloids,  medicinals,  illegal  or  controlled  substances,  caffeine,  vitamins,  ar;ficial  food  coloring  

•  Flavors  are  KNOWN  to  be  appealing  to  youth  

ConsMtuents  of  e-­‐juice:  NicoMne  

•  Nico;ne  effects:  low  doses  –  Complex  pharmacodynamics  –  neural  s;mulant  at  low  doses  and  a  depressant  at  high  doses  

•  S;mulates  memory  and  alertness.  People  who  use  tobacco  onen  depend  on  it  to  help  them  accomplish  certain  tasks  and  perform  well.  

•  Many  people  feel  a  sense  of  well-­‐being.    •  Decreases  the  appe;te  (for  this  reason,  the  fear  of  weight  gain  affects  some  people's  willingness  to  stop  smoking);  boosts  mood  and  may  relieve  minor  depression.    

•  Increases  intes;nal  ac;vity,  creates  more  saliva  and  phlegm,  increases  heart  rate  by  10  to  20  beats  per  minute;  increases  blood  pressure  by  5  to  10  mmHg.  

ConsMtuents  of  e-­‐juice:  NicoMne  

•  Nico;ne  overdose    –  Excess:  nausea  and  vomi;ng,  excessive  saliva;on,  abdominal  pain,  pallor,  swea;ng,  hypertension,  tachycardia,  ataxia,  tremor,  headache,  dizziness,  muscle  fascicula;ons,  and  seizures  

–  Death:  several  case  reports  of  suicide  by  nico;ne  •  Two  child  deaths  SO  FAR  from  e-­‐juice  reported  (Israel  and  US)  •  Surprisingly  few  deaths  given  toxicity    

 

NicoMne  Toxicity?  

•  The  dose  makes  the  poison  –  Oral  nico;ne  ~20%  bioavailable  

•  Lethal  dose  in  rats=  50mg/kg;  mice  3mg/kg  

•  Humans?    Stated  as  0.8mg/kg  (60mg),  which  would  make  it  more  toxic  than  cyanide  – Mul;ple  literature  reports  of  survival  at  6  mg/kg  –  Recent  review  suggests  6.5-­‐13mg/kg  LD50  

Archives of Toxicology, 2013 Mayer, Arch Toxicol 2014

Math  •  36mg/ml,  10ml=  360  mg  nico;ne  

–  Conven;onal  idea  of  60mg=death,  this  could  kill  6  people!  –  New  math=  it  would  s;ll  kill  an  adult  – My  4  year  old=17kg  

•  0.8mg/kg=10mg=0.4  ml!!  •  6.5-­‐13mg/kg=3-­‐6ml  

•  18mg/ml  is  more  standard  

Poison  Control  Calls  

AAP  AcMons  &  ReacMons  •  6/18/14:  Senate  Commerce  CommiHee  hearing  on  “Aggressive  E-­‐CigareHe  Marke;ng  and  Poten;al  Consequences  for  Youth”  

•  7/10/14:    Senate  bill  introduced  to  require  child-­‐proof  packaging  on  liquid  nico;ne  

•  9/16/14:  House  bill  introduced  

•  9/17/14:  Senate  bill  passed  in  commiHee  

•  12/31/14:  Bill  expired  

Too  late  to  save  a  life…  •  December  9,  2014,  EJ  Hotaling,  an  

18  month  old  from  upstate  NY,  ingested  nico;ne  refill  solu;on  while  his  mother  was  turning  on  his  favorite  TV  show  

•  He  seized  and  never  regained  consciousness  

•  He  is  the  first  child  to  die  in  the  US  from  refillable  nico;ne  

•  NY  Governor  Cuomo  signed  a  nico;ne  packaging  bill  into  law  on  12/29/14    

 

Photos: Times Union, 12/30/14

Child  NicoMne  Poisoning  PrevenMon  Act  of  2015    

•  Child  Nico;ne  Poisoning  Preven;on  Act  of  2015  (S.  142)  –  Re-­‐introduced  by  Sen.  Nelson  (D-­‐FL)  and  Sen.  AyoHe  (R-­‐NH)  and  10  other  

Senators  –  Grants  Consumer  Product  Safety  Commission  (CPSC)  authority  to  require  

child-­‐proof  packaging  for  nico;ne  refill  solu;ons  sold  to  consumers  (current  law  prohibits  CPSC  from  regula;ng  any  tobacco  products)  

–  The  bill  is  craned  narrowly  to  focus  only  on  liquid  nico;ne  and  its  safe  containment  from  children,  and  does  not  affect  the  manufacture  of  the  substance  nor  the  products  they  are  designed  to  refill  

•  2/26/15:  Bill  passed  CommiHee,  sent  to  full  Senate  

•  Awai;ng  introduc;on  in  House  (Republican  co-­‐sponsor  needed)  

Different  Experiences  By  User…  •  How  much  nico;ne  DO  you  get  per  puff?  

– Different  bioavailability  through  puffing  than  drinking  

– Depends  on  many  factors:  temperature  of  the  atomizer,  how  much  juice  is  atomized,  size  of  the  atomized  droplets,  depth  of  the  “puff”,  concentra;on  of  the  e-­‐juice    

•  Large  droplets  will  deposit  in  the  oropharynx  and  upper  airway  (venous  absorp;on)  

•  Small  droplets  can  get  deeper  –  into  alveoli  for  arterial  absorp;on  

What  are  the  health  harms?  •  Rela;ve  to  smoked  tobacco,  less  harmful    

–  No  tar  –  Variable  levels  of  nico;ne  

•  Rela;ve  to  NO  tobacco  or  medical  NRT    –  Growing  concerns  for  decreased  lung  func;on  (aldehydes)  –  Quality  control  –  adulterated  products  have  been  found  

•  Safety  of  flavor  when  heated  and  inhaled  is  unknown  •  Non-­‐  and  former  smokers  may  become  addicted  

•  May  maintain  combusted  tobacco  use  

 

New  AddicMon?  

•  The  adolescent  brain  appears  uniquely  suscep;ble  to  nico;ne  addic;on  

•  Animal  studies  show  that  nico;ne  exposure  during  adolescence  period  has  long-­‐standing  effects  in  the  brain  including  cell  damage  that  leads  to  both  immediate  and  persistent  behavior  changes.  

Slottkin, Neurotox & Teratol 2002

What  are  the  health  harms?  

•  At  present  (4/2015),  completely  unregulated  –  FDA  has  issued  their  Deeming  Document  for  proposed  rulemaking,  public  comments  closed  in  August  

– Might  come  out  in  June  2015?  For  ac;on  in  2  y…  –  No  Consumer  Products  Safety  Commission  oversight  (yet!)  –  ANYONE  can  manufacture  and  sell  – Most  of  the  market  s;ll  comes  from  China  

What  are  the  Public  Health  Harms?  •  Second-­‐hand  vapor  is  NOT  just  water  vapor  –  Emit  variable  levels  of  nico;ne  (1/10th  that  of  cigareHes),  plus  fine  par;cles  of  similar  size  to  that  of  cigareHes,  and  comparable  concentra;on  of  fine  par;cles  

–  Emit  low  levels  of  other  toxins:  formaldehyde,  acetaldehyde,  metals  

Czogala et al, Nicotine and Tobacco Research 2013 Fuoco et al, Environmental Pollution 2014

What  are  the  Public  Health  Harms?  

Surface Contamination Nicotine, which combines with indoor substances such as ozone and nitrous oxide to make irritants and carcingens (TSNAs), collects on surfaces from e-cigarette use

Goniewicz and Lee, Nicotine and Tobacco Research 2014

0

5

10

15

20

25

30 Serum nicotine

*

<5 ppb <5 ppb

1.8% nicotine 0% nicotine Room Air

ppb

Serum nicotine levels are elevated in neonatal mice exposed to 1.8% E-cig emissions twice a day for ten days

What  are  the  Public  Health  Harms?  

0  

10  

20  

30  

40  

50  

60  

70  

80  

RA   0%  NicoMne   1.8%  NicoMne  

p=<0.001

p=<0.001

Room air 0% nicotine 1.8% nicotine

Alveolar growth is impaired in newborn mice exposed to E-cigarette emissions

Mea

n lin

ear i

nter

cept

(ar

bitr

ary

units

)

What  are  the  Public  Health  Harms?  

0 0.2 0.4 0.6 0.8

1 1.2 1.4 1.6 1.8

2

Room Air 0% Nicotine 1.8% Nicotine

p<0.04 p<0.001

KI67

 qua

nMficaM

on  

Lung  funcMon  is  impaired    in  neonatal  mice  exposed  to    

E-­‐cigare)e  emissions    

McGrrath-Morrow S, et al. PLoS One, Feb. 2015

What  are  the  Public  Health  Harms?  

•  Re-­‐normalizing  the  image  of  smoking  –  Allowed  in  places  where  smoking  is  not  allowed  –  Adver;sing  is  completely  unrestricted,  with  TV  ads  for  the  first  ;me  since  1971  

–  Largely  indis;nguishable  from  cigareHes  

Why  e-­‐cigare)es/vape  pen/e-­‐hookah?  

•  Curiosity  •  Reduc;on  of  other  tobacco  products  

•  Cessa;on  

•  Stealth  •  Percep;on  of  a  safer  product  

•  Social  acceptance  

Trends  in  adult  current  use  of  e-­‐cigare)es  2010-­‐2013  

McMillen, et al. “Trends in electronic cigarette use among US adults. FAMRI meeting 2014

0  

2  

4  

6  

8  

10  

12  

14  

16  

Overall   18-­‐24  years   25-­‐44  years   45-­‐64  years   65+  years  

2010  

2011  

2012  

2013  

Is  there  evidence  of  efficacy  for  cessaMon?  

Very  limited:  most  suggests  that  people  cut  down  and  don’t  stop  completely…

More  evidence  is  accumula;ng.  

2013  Lancet  Paper:  as  good  as  NRT  patch  

Bullen et al, Lancet 2013

Effects  of  DuraMon  of  E-­‐Cigare)e  Use  •  n=159.  Longer  e-­‐cig  use  led  to  higher  likelihood  of  being  an  ex-­‐smoker  

than  being  dual  user,  &  fewer  combusted  cigareHes  among  all  

Lechner et al. Nicotine and Tobacco Research, 2014

Best  Evidence  for  CessaMon  yet…  (among  those  moMvated  to  quit)  

Brown et al. Addiction, 2014

Meta-­‐analysis  –  Glantz  et  al  2015  

11 studies = OR = 0.72 (95% CI 0.53- 0.98)

Smokers who use e-cigarettes are about 30% less likely to quit

What  happens  now?  

•  Expected  that  the  market  will  con;nue  to  explode  

•  Expected  that  FDA  will  assert  jurisdic;on    –  Improved  quality  control  and  produc;on  standards  

Source: Winston-Salem Journal, September 15, 2013

Vuse – launched 2013 Blu – purchased 2012 MarkTen – launch 2013

What  happens  now?  

•  Expected  that  the  market  will  con;nue  to  explode  

•  Expected  FDA  jurisdic;on  –  proposed  rule  April  2014  –  Improved  quality  control  and  produc;on  standards  –  No  sales  <18  years  –  Health  warning  labels  –  No  vending  machine  sales  –  No  marke;ng  implying  “healthy”  or  “safe”  

•  Final  rule  could  come  as  early  as  June  2015  – Would  go  into  effect  2  years  AFTER  final  rule  – Misses  several  aspects:  flavors,  child-­‐proof  packaging,  marke;ng,  online  sales  

E-­‐Cigare)e  Laws  by  State  

So  what  to  do?  •  Caveat  emptor  

– Must  have  a  regulated  product  for  an  informed  consumer,  with  fully  disclosed  labeling  

•  Research  is  impera;ve  to  assess  second  hand  vapor  effects  (of  all  kinds),  addic;on  poten;al  and  dual-­‐use  maintenance  

•  Un;l  we  know  more  about  “e-­‐anything”  and  cessa;on,  we  can  s;ll  recommend  medicinal  NRT,  quit  lines  and  support  while  people  are  becoming  non-­‐tobacco  users  

“Responsibly  marketed  and  properly  regulated,  it  is  possible  that  e-­‐cigareHes  could  benefit  public  health  if  they  help  significantly  reduce  the  number  of  people  who  use  conven;onal  cigareHes  and  die  of  tobacco-­‐related  disease.  But  in  the  absence  of  FDA  oversight,  the  easy  availability  of  nico;ne  in  uncontrolled  quan;;es,  packaging  and  flavors  and  marke;ng  that  appeals  to  youth  raises  serious  concerns.”    

–   MaH  Meyer,  Campaign  for  Tobacco  Free  Kids,  4/3/14  

Discussion